
Announcement: Execution of Memorandum of Understanding
Posted on: Tuesday, December 08, 2009
The Company is pleased to announce that it has executed a Memorandum of Understanding (MOU) with its proposed partner to develop, produce, market and distribute edible films. The MOU sets out the obligations of both parties and the work to be undertaken to determine the feasibility of a joint venture or similar contractual relationship. This project, along with several other specific projects, is a high commercial priority of the Company and although there can be no assurance that a formal agreement will be concluded, the Company has detailed a senior team to manage the project. The work to be undertaken is complex and extensive and includes: formulation and experimentation of edible film trials; feasibility, cost analysis and development of a programme to establish cGMP facilities; assessment of robustness of IP; market research; regulatory procedures and submissions; and determination of a beneficial business model. In recent months several trials have been undertaken on various film formulations with encouraging results. The Company has one contract with a large pharma company for which trials will commence in the near future, and is in discussions with a major global company for whom it is anticipated samples will be provided very early in the New Year. The Company will update shareholders on progress when milestones are achieved.
Other current news items
Distribution Agreement for Menoflavon® in JordanPosted on: Tuesday, May 25, 2010
Kudos™ Licensing Agreement
Posted on: Friday, May 14, 2010
Distribution Agreement for Menoflavon® in Singapore
Posted on: Thursday, April 15, 2010
Meldex International PLC 2008 Financial Statements
Posted on: Thursday, January 07, 2010
Distribution Agreement for Menoflavon® in the Netherlands
Posted on: Tuesday, November 03, 2009
Restoration of Registrar Services
Posted on: Thursday, October 15, 2009
Company Update
Posted on: Tuesday, October 13, 2009
Distribution Agreement for Menoflavon® in Canada
Posted on: Friday, October 02, 2009
Company Update
Posted on: Friday, September 25, 2009
Distribution Agreement for Menoflavon® in Austria
Posted on: Friday, September 18, 2009
Update on the Secured Loan Note Offer
Posted on: Wednesday, September 02, 2009
Result of Annual General Meeting
Posted on: Friday, August 28, 2009
Distribution Agreement for Menoflavon® and Melprotect® in United Arab Emirates
Posted on: Monday, August 24, 2009
Secured Loan Note Update and Notice of AGM
Posted on: Wednesday, August 05, 2009
Secured Loan Note update
Posted on: Friday, July 24, 2009
Extension to Secured Loan Note offer deadline
Posted on: Wednesday, July 22, 2009
Appointment of Consultant Project Manager
Posted on: Thursday, July 16, 2009
Distribution Agreement for Menoflavon® in Germany
Posted on: Friday, July 10, 2009
Appointment of Consultant Project Manager
Posted on: Friday, July 10, 2009
Proceedings issued against former Directors
Posted on: Saturday, July 04, 2009
Collaboration Agreement for Meltums™ Pharma Development
Posted on: Thursday, July 02, 2009
Secured Loan Note Applications
Posted on: Wednesday, July 01, 2009
Menoflavon® Distribution Agreements
Posted on: Monday, June 29, 2009
Launch of Secured Loan Note Offer
Posted on: Thursday, June 25, 2009
Distribution Agreement for Menoflavon® in Belgium
Posted on: Wednesday, June 24, 2009
Company Update
Posted on: Monday, June 15, 2009
Product Availability Matrix
Posted on: Thursday, June 11, 2009
Cancellation of Share Options
Posted on: Wednesday, June 03, 2009
Oradisc™ Benzocaine now at Regulatory stage
Posted on: Tuesday, May 05, 2009
Hintz Joint Venture announcement
Posted on: Thursday, April 09, 2009

